Stocks
Single names, sectors, valuations and the trades behind the tape, explained in plain language.
Aramark's Data Center Bet Could Boost Results in Late 2025
Truist Securities sees Aramark's Nexus data center business as a future growth engine, though contributions may take two to three quarters.
Biotech and AI stocks tumble: MapLight, AiRWA, and Nvidia all fall
MapLight Therapeutics plunged 68% after its schizophrenia trial showed mixed results, while AiRWA dropped 74% on a $50 million acquisition d
Neotech Metals hires ANZAPLAN to design rare earth processing plan for Hecla-Kilmer
Neotech Metals has hired Germany's Dorfner ANZAPLAN to design a processing flowsheet for its Hecla-Kilmer rare earth project in Ontario. The
Benton Resources spins out Great Burnt copper project into Silverback Metals
Benton Resources is spinning out several mineral projects, including Newfoundland's Great Burnt copper deposit, into privately held Silverba
UBS Raises Sonoco Price Target to $61 on Strong Industrial Packaging Demand
UBS has raised its price target for Sonoco Products to $61, keeping a neutral rating. The bank sees the company's industrial packaging segme
JetBlue Overhauls Fare Options as Airlines Embrace Tiered Pricing Ahead of Earnings
JetBlue is rolling out new fare options that let travelers customize seat selection and refundability, days before its second-quarter earnin
McDonald's Faces Soft Q2, but UBS Sees Recovery in Second Half
McDonald's may report a soft second quarter, with UBS forecasting US same-store sales growth of only 0.5%. However, the bank expects a bette
DKSH expands European healthcare push with Bayer contraceptive brand buy
DKSH is deepening its European healthcare and ingredients business by acquiring Bayer's Meliane contraceptive brand and securing an exclusiv
Charter Communications faces deeper broadband losses after Cox deal closes
RBC Capital Markets expects Charter Communications' broadband subscriber losses to deepen in 2026-27. The pending Cox deal, closing in mid-t
Legend Biotech stock drops 14% despite RBC backing for in vivo CAR-T program
RBC Capital Markets gave a vote of confidence to Legend Biotech's early in vivo CAR-T data, but the stock still slid more than 14% on Monday
Morgan Stanley cuts Las Vegas Sands targets on slower Macau, Singapore trends
Morgan Stanley trimmed its forecasts and price target for Las Vegas Sands after the casino operator reported softer trends in Macau and Sing
BofA Starts ITG Coverage, Sees Broadband Upgrade Tailwinds
Bank of America Securities started coverage on ITG this week, arguing the network-services contractor is well-positioned to benefit from the